Detalles de la búsqueda
1.
The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation.
FASEB J
; 38(2): e23413, 2024 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243760
2.
The cystathionine-ß-synthase domains on the guanosine 5''-monophosphate reductase and inosine 5'-monophosphate dehydrogenase enzymes from Leishmania regulate enzymatic activity in response to guanylate and adenylate nucleotide levels.
Mol Microbiol
; 100(5): 824-40, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26853689
3.
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
J Womens Health (Larchmt)
; 33(4): 480-490, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301149
4.
ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity.
Invest New Drugs
; 31(6): 1409-23, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959266
5.
Severity and worsening of fatigue among individuals with multiple sclerosis.
Mult Scler J Exp Transl Clin
; 9(2): 20552173231167079, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101754
6.
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.
Breast Cancer Res Treat
; 133(1): 217-26, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21915635
7.
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis.
Onco Targets Ther
; 8: 911-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960662
Resultados
1 -
7
de 7
1
Próxima >
>>